Effects of Autologous Blood Injection Versus Platelet Rich Plasma on Chronic Plantar Fasciitis
CompletedPhase 3NCT05240872
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To explore effects of Autologous Blood Injection versus Platelet Rich plasma injection for treatment of chronic plantar fasciitis
Study details
- Official title
- Is There Any Advantage of PRP Over Autologous Blood Injection in the Treatment of Chronic Plantar Fasciitis? A Prospective Randomized Double Blinded Study
- Conditions
- Plantar Fascitis
- Interventions
- Biological: PRP injection
- Biological: ABI injection
- Sponsor
- Istanbul Training and Research Hospital
- Start date
- 2020-03-01
- Primary completion
- 2020-10-30
- Sex
- All
- Age range
- from 40 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Participants who were diagnosed with chronic plantar fasciitis 2. Nonresponded to o conservative treatment (stretching exercises, nonsteroidal anti-inflammatory drugs, and heel pads) for at least 6 weeks 3. Patient should be able to understand the informed consent about type of treatment and blindness and randomization 4. Visual analog scale pain higher than 5 (on a 10-point visual analog scale) Exclusion Criteria: 1. previous history of any type of local injection treatment for heel pain 2. history of surgery for heel pain, foot and ankle disorders, fractures 3. Associated pathology involving the lower limb such as * tarsal tunnel syndrome * effusion of the ankle indicating an intra-articular disease * Peroneal/Achilles/tibialis tendons pathology * any obvious deformity of foot and ankle, 4. Patients with systemic disorder like diabetes mellitus, ankylosing spondylitis rheumatoid arthritis, hematological disease, or gout 5. Pregnancy 6. Use of antiocoagulation -
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05240872